Pulse Endovascular ReperFUSION for Acute Ischemic Stroke (PERFUSION AIS)
PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study
Sponsor: Euphrates Vascular, Inc.
A NA clinical study on Acute Ischemic Stroke AIS and Cerebral Arterial Disease, this trial is actively recruiting participants. The trial is conducted by Euphrates Vascular, Inc. and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Euphrates Vascular, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .